BACH1 and Parkinson disease: In that regard, we have reported a chemical derivative of cannabidiol with dual activity and protective effects in a cellular model of Huntington's disease [19] and a recent work characterised a novel dual BACH1/KEAP1 inhibitor with protective effects in a Parkinson's model [18].